Published on in Vol 9, No 9 (2020): September
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/17850, first published
.
Prospective Comparison of 18F-Choline Positron Emission Tomography/Computed Tomography (PET/CT) and 18F-Fluorodeoxyglucose (FDG) PET/CT in the Initial Workup of Multiple Myeloma: Study Protocol of a Prospective Imaging Trial
Prospective Comparison of 18F-Choline Positron Emission Tomography/Computed Tomography (PET/CT) and 18F-Fluorodeoxyglucose (FDG) PET/CT in the Initial Workup of Multiple Myeloma: Study Protocol of a Prospective Imaging Trial
Journals
- von Hinten J, Kircher M, Dierks A, Pfob C, Higuchi T, Pomper M, Rowe S, Buck A, Samnick S, Werner R, Lapa C. Molecular Imaging in Multiple Myeloma—Novel PET Radiotracers Improve Patient Management and Guide Therapy. Frontiers in Nuclear Medicine 2022;2 View
- Garrastachu Zumarán P, García Megías I, Mangas Losada M, Mendoza Melero A, Villanueva Torres A, Boulvard Chollet X, Romero Robles L, Hernández Pérez P, Ramírez Lasanta R, Delgado Bolton R. Multitracer PET/CT with [18F]Fluorodeoxiglucose and [18F]Fluorocholine in the Initial Staging of Multiple Myeloma Patients Applying the IMPeTus Criteria: A Pilot Study. Diagnostics 2023;13(9):1570 View
- Travascio L, Morales-Lozano M, Guglielmo P, Cimini A, van Essen M, Stavrou P, Vatsa R, Grisanti F. PET radiopharmaceuticals beyond 2-[18F]FDG for the evaluation of multiple myeloma and smoldering multiple myeloma. Clinical and Translational Imaging 2025;13(4):379 View